The global Lung Cancer Screening Software market was valued at US$ 1706 million in 2025 and is anticipated to reach US$ 5434 million by 2032, at a CAGR of 18.0% from 2026 to 2032.

Lung Cancer Screening Software Market

Lung cancer screening software is medical software based on medical imaging (primarily low-dose CT) and algorithm models. It is used to automatically detect lung nodules, analyze morphological characteristics, assess malignancy risk, and assist in follow-up management. Its goal is to improve the early detection rate of lung cancer, reduce the missed diagnosis rate, and support clinical decision-making and population screening.

Upstream components mainly include medical imaging data sources (CT equipment, imaging centers), computing power and cloud infrastructure, algorithm frameworks, and data annotation resources. Downstream components primarily target hospital radiology departments, regional public health screening projects, physical examination institutions, and health management and insurance-related service scenarios.

Global Market Future Development Trends

With the increasing incidence of lung cancer and the aging population, low-dose CT screening is being included in recommended or pilot programs in more and more countries. Traditional manual image interpretation is insufficient to support large-scale screening, making efficient and replicable software solutions a necessity and driving the rapid deployment of lung cancer screening software in hospitals and regional population screening.

The market is evolving from single nodule detection to risk stratification, follow-up comparison, multi-temporal analysis, and automated reporting. Algorithm stability, cross-device generalization ability, and clinical interpretability have become core competitive advantages, elevating the value of software from an "auxiliary tool" to a "key node in the screening process."

Against increasingly stringent regulatory requirements from the FDA, CE, and NMPA, compliance certification has become a market entry barrier. In the future, software will increasingly take the form of platforms, integrating with PACS, regional screening systems, and cloud services, transforming from single-point sales to long-term service revenue through subscription or pay-per-view models.

This report delivers a comprehensive overview of the global Lung Cancer Screening Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lung Cancer Screening Software. The Lung Cancer Screening Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Lung Cancer Screening Software market comprehensively. Regional market sizes by Type, by Application, by Screening Technologies, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Lung Cancer Screening Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Lung Cancer Screening Software Market Report

Report Metric	Details
Report Name	Lung Cancer Screening Software Market
Accounted market size in 2025	US$ 1706 million
Forecasted market size in 2032	US$ 5434 million
CAGR	18.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Cloud-Based Web-Based
Segment by Screening Technologies	Nodule Detection Nodule Analysis Full-Process Screening Predictive Assessment
Segment by System Integration Level	Standalone AI Software PACS/RIS Integrated Plugin Built-in Solution for Imaging Equipment Regional Screening Platform System
Segment by Application	Hospitals Medical Examination Institutions Public Health Screening Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, United Imaging Healthcare, InferVision, Airdoc, VUNO, Lunit, Qure.ai, Riverain Technologies, Zebra Medical Vision, Arterys, Deepwise, EverFortune AI
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Screening Technologies, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Lung Cancer Screening Software companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Lung Cancer Screening Software Market growing?

Ans: The Lung Cancer Screening Software Market witnessing a CAGR of 18.0% during the forecast period 2026-2032.

What is the Lung Cancer Screening Software Market size in 2032?

Ans: The Lung Cancer Screening Software Market size in 2032 will be US$ 5434 million.

Who are the main players in the Lung Cancer Screening Software Market report?

Ans: The main players in the Lung Cancer Screening Software Market are Siemens Healthineers, GE HealthCare, Philips Healthcare, Canon Medical Systems, United Imaging Healthcare, InferVision, Airdoc, VUNO, Lunit, Qure.ai, Riverain Technologies, Zebra Medical Vision, Arterys, Deepwise, EverFortune AI

What are the Application segmentation covered in the Lung Cancer Screening Software Market report?

Ans: The Applications covered in the Lung Cancer Screening Software Market report are Hospitals, Medical Examination Institutions, Public Health Screening, Others

What are the Type segmentation covered in the Lung Cancer Screening Software Market report?

Ans: The Types covered in the Lung Cancer Screening Software Market report are Cloud-Based, Web-Based

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Screening Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Cloud-Based

1.2.3 Web-Based

1.3 Market by Screening Technologies

1.3.1 Global Lung Cancer Screening Software Market Size Growth Rate by Screening Technologies: 2021 vs 2025 vs 2032

1.3.2 Nodule Detection

1.3.3 Nodule Analysis

1.3.4 Full-Process Screening

1.3.5 Predictive Assessment

1.4 Market by System Integration Level

1.4.1 Global Lung Cancer Screening Software Market Size Growth Rate by System Integration Level: 2021 vs 2025 vs 2032

1.4.2 Standalone AI Software

1.4.3 PACS/RIS Integrated Plugin

1.4.4 Built-in Solution for Imaging Equipment

1.4.5 Regional Screening Platform System

1.5 Market by Application

1.5.1 Global Lung Cancer Screening Software Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Hospitals

1.5.3 Medical Examination Institutions

1.5.4 Public Health Screening

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Screening Software Market Perspective (2021–2032)

2.2 Global Lung Cancer Screening Software Growth Trends by Region

2.2.1 Global Lung Cancer Screening Software Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Lung Cancer Screening Software Historic Market Size by Region (2021–2026)

2.2.3 Lung Cancer Screening Software Forecasted Market Size by Region (2027–2032)

2.3 Lung Cancer Screening Software Market Dynamics

2.3.1 Lung Cancer Screening Software Industry Trends

2.3.2 Lung Cancer Screening Software Market Drivers

2.3.3 Lung Cancer Screening Software Market Challenges

2.3.4 Lung Cancer Screening Software Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Screening Software Players by Revenue

3.1.1 Global Top Lung Cancer Screening Software Players by Revenue (2021–2026)

3.1.2 Global Lung Cancer Screening Software Revenue Market Share by Players (2021–2026)

3.2 Global Top Lung Cancer Screening Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Lung Cancer Screening Software Revenue

3.4 Global Lung Cancer Screening Software Market Concentration Ratio

3.4.1 Global Lung Cancer Screening Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Screening Software Revenue in 2025

3.5 Global Key Players of Lung Cancer Screening Software Head Offices and Areas Served

3.6 Global Key Players of Lung Cancer Screening Software, Products and Applications

3.7 Global Key Players of Lung Cancer Screening Software, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Lung Cancer Screening Software Breakdown Data by Type

4.1 Global Lung Cancer Screening Software Historic Market Size by Type (2021–2026)

4.2 Global Lung Cancer Screening Software Forecasted Market Size by Type (2027–2032)

5 Lung Cancer Screening Software Breakdown Data by Application

5.1 Global Lung Cancer Screening Software Historic Market Size by Application (2021–2026)

5.2 Global Lung Cancer Screening Software Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Lung Cancer Screening Software Market Size (2021–2032)

6.2 North America Lung Cancer Screening Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Lung Cancer Screening Software Market Size by Country (2021–2026)

6.4 North America Lung Cancer Screening Software Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Screening Software Market Size (2021–2032)

7.2 Europe Lung Cancer Screening Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Lung Cancer Screening Software Market Size by Country (2021–2026)

7.4 Europe Lung Cancer Screening Software Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Screening Software Market Size (2021–2032)

8.2 Asia-Pacific Lung Cancer Screening Software Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Lung Cancer Screening Software Market Size by Region (2021–2026)

8.4 Asia-Pacific Lung Cancer Screening Software Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Lung Cancer Screening Software Market Size (2021–2032)

9.2 Latin America Lung Cancer Screening Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Lung Cancer Screening Software Market Size by Country (2021–2026)

9.4 Latin America Lung Cancer Screening Software Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Screening Software Market Size (2021–2032)

10.2 Middle East & Africa Lung Cancer Screening Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Lung Cancer Screening Software Market Size by Country (2021–2026)

10.4 Middle East & Africa Lung Cancer Screening Software Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Siemens Healthineers

11.1.1 Siemens Healthineers Company Details

11.1.2 Siemens Healthineers Business Overview

11.1.3 Siemens Healthineers Lung Cancer Screening Software Introduction

11.1.4 Siemens Healthineers Revenue in Lung Cancer Screening Software Business (2021–2026)

11.1.5 Siemens Healthineers Recent Development

11.2 GE HealthCare

11.2.1 GE HealthCare Company Details

11.2.2 GE HealthCare Business Overview

11.2.3 GE HealthCare Lung Cancer Screening Software Introduction

11.2.4 GE HealthCare Revenue in Lung Cancer Screening Software Business (2021–2026)

11.2.5 GE HealthCare Recent Development

11.3 Philips Healthcare

11.3.1 Philips Healthcare Company Details

11.3.2 Philips Healthcare Business Overview

11.3.3 Philips Healthcare Lung Cancer Screening Software Introduction

11.3.4 Philips Healthcare Revenue in Lung Cancer Screening Software Business (2021–2026)

11.3.5 Philips Healthcare Recent Development

11.4 Canon Medical Systems

11.4.1 Canon Medical Systems Company Details

11.4.2 Canon Medical Systems Business Overview

11.4.3 Canon Medical Systems Lung Cancer Screening Software Introduction

11.4.4 Canon Medical Systems Revenue in Lung Cancer Screening Software Business (2021–2026)

11.4.5 Canon Medical Systems Recent Development

11.5 United Imaging Healthcare

11.5.1 United Imaging Healthcare Company Details

11.5.2 United Imaging Healthcare Business Overview

11.5.3 United Imaging Healthcare Lung Cancer Screening Software Introduction

11.5.4 United Imaging Healthcare Revenue in Lung Cancer Screening Software Business (2021–2026)

11.5.5 United Imaging Healthcare Recent Development

11.6 InferVision

11.6.1 InferVision Company Details

11.6.2 InferVision Business Overview

11.6.3 InferVision Lung Cancer Screening Software Introduction

11.6.4 InferVision Revenue in Lung Cancer Screening Software Business (2021–2026)

11.6.5 InferVision Recent Development

11.7 Airdoc

11.7.1 Airdoc Company Details

11.7.2 Airdoc Business Overview

11.7.3 Airdoc Lung Cancer Screening Software Introduction

11.7.4 Airdoc Revenue in Lung Cancer Screening Software Business (2021–2026)

11.7.5 Airdoc Recent Development

11.8 VUNO

11.8.1 VUNO Company Details

11.8.2 VUNO Business Overview

11.8.3 VUNO Lung Cancer Screening Software Introduction

11.8.4 VUNO Revenue in Lung Cancer Screening Software Business (2021–2026)

11.8.5 VUNO Recent Development

11.9 Lunit

11.9.1 Lunit Company Details

11.9.2 Lunit Business Overview

11.9.3 Lunit Lung Cancer Screening Software Introduction

11.9.4 Lunit Revenue in Lung Cancer Screening Software Business (2021–2026)

11.9.5 Lunit Recent Development

11.10 Qure.ai

11.10.1 Qure.ai Company Details

11.10.2 Qure.ai Business Overview

11.10.3 Qure.ai Lung Cancer Screening Software Introduction

11.10.4 Qure.ai Revenue in Lung Cancer Screening Software Business (2021–2026)

11.10.5 Qure.ai Recent Development

11.11 Riverain Technologies

11.11.1 Riverain Technologies Company Details

11.11.2 Riverain Technologies Business Overview

11.11.3 Riverain Technologies Lung Cancer Screening Software Introduction

11.11.4 Riverain Technologies Revenue in Lung Cancer Screening Software Business (2021–2026)

11.11.5 Riverain Technologies Recent Development

11.12 Zebra Medical Vision

11.12.1 Zebra Medical Vision Company Details

11.12.2 Zebra Medical Vision Business Overview

11.12.3 Zebra Medical Vision Lung Cancer Screening Software Introduction

11.12.4 Zebra Medical Vision Revenue in Lung Cancer Screening Software Business (2021–2026)

11.12.5 Zebra Medical Vision Recent Development

11.13 Arterys

11.13.1 Arterys Company Details

11.13.2 Arterys Business Overview

11.13.3 Arterys Lung Cancer Screening Software Introduction

11.13.4 Arterys Revenue in Lung Cancer Screening Software Business (2021–2026)

11.13.5 Arterys Recent Development

11.14 Deepwise

11.14.1 Deepwise Company Details

11.14.2 Deepwise Business Overview

11.14.3 Deepwise Lung Cancer Screening Software Introduction

11.14.4 Deepwise Revenue in Lung Cancer Screening Software Business (2021–2026)

11.14.5 Deepwise Recent Development

11.15 EverFortune AI

11.15.1 EverFortune AI Company Details

11.15.2 EverFortune AI Business Overview

11.15.3 EverFortune AI Lung Cancer Screening Software Introduction

11.15.4 EverFortune AI Revenue in Lung Cancer Screening Software Business (2021–2026)

11.15.5 EverFortune AI Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Siemens Healthineers

GE Healthcare

Philips Healthcare

Canon Medical Systems

United Imaging Healthcare

Riverain Technologies

List of Tables

Table 1. Global Lung Cancer Screening Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Cloud-Based

Table 3. Key Players of Web-Based

Table 4. Global Lung Cancer Screening Software Market Size Growth Rate by Screening Technologies (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of Nodule Detection

Table 6. Key Players of Nodule Analysis

Table 7. Key Players of Full-Process Screening

Table 8. Key Players of Predictive Assessment

Table 9. Global Lung Cancer Screening Software Market Size Growth Rate by System Integration Level (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Standalone AI Software

Table 11. Key Players of PACS/RIS Integrated Plugin

Table 12. Key Players of Built-in Solution for Imaging Equipment

Table 13. Key Players of Regional Screening Platform System

Table 14. Global Lung Cancer Screening Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global Lung Cancer Screening Software Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global Lung Cancer Screening Software Market Size by Region (US$ Million), 2021–2026

Table 17. Global Lung Cancer Screening Software Market Share by Region (2021–2026)

Table 18. Global Lung Cancer Screening Software Forecasted Market Size by Region (US$ Million), 2027–2032

Table 19. Global Lung Cancer Screening Software Market Share by Region (2027–2032)

Table 20. Lung Cancer Screening Software Market Trends

Table 21. Lung Cancer Screening Software Market Drivers

Table 22. Lung Cancer Screening Software Market Challenges

Table 23. Lung Cancer Screening Software Market Restraints

Table 24. Global Lung Cancer Screening Software Revenue by Players (US$ Million), 2021–2026

Table 25. Global Lung Cancer Screening Software Market Share by Players (2021–2026)

Table 26. Global Top Lung Cancer Screening Software Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lung Cancer Screening Software Revenue, 2025

Table 27. Ranking of Global Top Lung Cancer Screening Software Companies by Revenue (US$ Million) in 2025

Table 28. Global 5 Largest Players Market Share by Lung Cancer Screening Software Revenue (CR5 and HHI), 2021–2026

Table 29. Global Key Players of Lung Cancer Screening Software, Headquarters and Area Served

Table 30. Global Key Players of Lung Cancer Screening Software, Products and Applications

Table 31. Global Key Players of Lung Cancer Screening Software, Date of General Availability (GA)

Table 32. Mergers and Acquisitions, Expansion Plans

Table 33. Global Lung Cancer Screening Software Market Size by Type (US$ Million), 2021–2026

Table 34. Global Lung Cancer Screening Software Revenue Market Share by Type (2021–2026)

Table 35. Global Lung Cancer Screening Software Forecasted Market Size by Type (US$ Million), 2027–2032

Table 36. Global Lung Cancer Screening Software Revenue Market Share by Type (2027–2032)

Table 37. Global Lung Cancer Screening Software Market Size by Application (US$ Million), 2021–2026

Table 38. Global Lung Cancer Screening Software Revenue Market Share by Application (2021–2026)

Table 39. Global Lung Cancer Screening Software Forecasted Market Size by Application (US$ Million), 2027–2032

Table 40. Global Lung Cancer Screening Software Revenue Market Share by Application (2027–2032)

Table 41. North America Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. North America Lung Cancer Screening Software Market Size by Country (US$ Million), 2021–2026

Table 43. North America Lung Cancer Screening Software Market Size by Country (US$ Million), 2027–2032

Table 44. Europe Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Europe Lung Cancer Screening Software Market Size by Country (US$ Million), 2021–2026

Table 46. Europe Lung Cancer Screening Software Market Size by Country (US$ Million), 2027–2032

Table 47. Asia-Pacific Lung Cancer Screening Software Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 48. Asia-Pacific Lung Cancer Screening Software Market Size by Region (US$ Million), 2021–2026

Table 49. Asia-Pacific Lung Cancer Screening Software Market Size by Region (US$ Million), 2027–2032

Table 50. Latin America Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 51. Latin America Lung Cancer Screening Software Market Size by Country (US$ Million), 2021–2026

Table 52. Latin America Lung Cancer Screening Software Market Size by Country (US$ Million), 2027–2032

Table 53. Middle East & Africa Lung Cancer Screening Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 54. Middle East & Africa Lung Cancer Screening Software Market Size by Country (US$ Million), 2021–2026

Table 55. Middle East & Africa Lung Cancer Screening Software Market Size by Country (US$ Million), 2027–2032

Table 56. Siemens Healthineers Company Details

Table 57. Siemens Healthineers Business Overview

Table 58. Siemens Healthineers Lung Cancer Screening Software Product

Table 59. Siemens Healthineers Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 60. Siemens Healthineers Recent Development

Table 61. GE HealthCare Company Details

Table 62. GE HealthCare Business Overview

Table 63. GE HealthCare Lung Cancer Screening Software Product

Table 64. GE HealthCare Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 65. GE HealthCare Recent Development

Table 66. Philips Healthcare Company Details

Table 67. Philips Healthcare Business Overview

Table 68. Philips Healthcare Lung Cancer Screening Software Product

Table 69. Philips Healthcare Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 70. Philips Healthcare Recent Development

Table 71. Canon Medical Systems Company Details

Table 72. Canon Medical Systems Business Overview

Table 73. Canon Medical Systems Lung Cancer Screening Software Product

Table 74. Canon Medical Systems Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 75. Canon Medical Systems Recent Development

Table 76. United Imaging Healthcare Company Details

Table 77. United Imaging Healthcare Business Overview

Table 78. United Imaging Healthcare Lung Cancer Screening Software Product

Table 79. United Imaging Healthcare Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 80. United Imaging Healthcare Recent Development

Table 81. InferVision Company Details

Table 82. InferVision Business Overview

Table 83. InferVision Lung Cancer Screening Software Product

Table 84. InferVision Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 85. InferVision Recent Development

Table 86. Airdoc Company Details

Table 87. Airdoc Business Overview

Table 88. Airdoc Lung Cancer Screening Software Product

Table 89. Airdoc Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 90. Airdoc Recent Development

Table 91. VUNO Company Details

Table 92. VUNO Business Overview

Table 93. VUNO Lung Cancer Screening Software Product

Table 94. VUNO Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 95. VUNO Recent Development

Table 96. Lunit Company Details

Table 97. Lunit Business Overview

Table 98. Lunit Lung Cancer Screening Software Product

Table 99. Lunit Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 100. Lunit Recent Development

Table 101. Qure.ai Company Details

Table 102. Qure.ai Business Overview

Table 103. Qure.ai Lung Cancer Screening Software Product

Table 104. Qure.ai Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 105. Qure.ai Recent Development

Table 106. Riverain Technologies Company Details

Table 107. Riverain Technologies Business Overview

Table 108. Riverain Technologies Lung Cancer Screening Software Product

Table 109. Riverain Technologies Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 110. Riverain Technologies Recent Development

Table 111. Zebra Medical Vision Company Details

Table 112. Zebra Medical Vision Business Overview

Table 113. Zebra Medical Vision Lung Cancer Screening Software Product

Table 114. Zebra Medical Vision Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 115. Zebra Medical Vision Recent Development

Table 116. Arterys Company Details

Table 117. Arterys Business Overview

Table 118. Arterys Lung Cancer Screening Software Product

Table 119. Arterys Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 120. Arterys Recent Development

Table 121. Deepwise Company Details

Table 122. Deepwise Business Overview

Table 123. Deepwise Lung Cancer Screening Software Product

Table 124. Deepwise Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 125. Deepwise Recent Development

Table 126. EverFortune AI Company Details

Table 127. EverFortune AI Business Overview

Table 128. EverFortune AI Lung Cancer Screening Software Product

Table 129. EverFortune AI Revenue in Lung Cancer Screening Software Business (US$ Million), 2021–2026

Table 130. EverFortune AI Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Lung Cancer Screening Software Picture

Figure 2. Global Lung Cancer Screening Software Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Lung Cancer Screening Software Market Share by Type: 2025 vs 2032

Figure 4. Cloud-Based Features

Figure 5. Web-Based Features

Figure 6. Global Lung Cancer Screening Software Market Size Comparison by Screening Technologies (US$ Million), 2021–2032

Figure 7. Nodule Detection Features

Figure 8. Nodule Analysis Features

Figure 9. Full-Process Screening Features

Figure 10. Predictive Assessment Features

Figure 11. Global Lung Cancer Screening Software Market Size Comparison by System Integration Level (US$ Million), 2021–2032

Figure 12. Standalone AI Software Features

Figure 13. PACS/RIS Integrated Plugin Features

Figure 14. Built-in Solution for Imaging Equipment Features

Figure 15. Regional Screening Platform System Features

Figure 16. Global Lung Cancer Screening Software Market Size by Application (US$ Million), 2021–2032

Figure 17. Global Lung Cancer Screening Software Market Share by Application: 2025 vs 2032

Figure 18. Hospitals Case Studies

Figure 19. Medical Examination Institutions Case Studies

Figure 20. Public Health Screening Case Studies

Figure 21. Others Case Studies

Figure 22. Lung Cancer Screening Software Report Years Considered

Figure 23. Global Lung Cancer Screening Software Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 24. Global Lung Cancer Screening Software Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global Lung Cancer Screening Software Market Share by Region: 2025 vs 2032

Figure 26. Global Lung Cancer Screening Software Market Share by Players in 2025

Figure 27. Global Lung Cancer Screening Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Lung Cancer Screening Software Revenue in 2025

Figure 29. North America Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. North America Lung Cancer Screening Software Market Share by Country (2021–2032)

Figure 31. United States Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Canada Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Lung Cancer Screening Software Market Share by Country (2021–2032)

Figure 35. Germany Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. France Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. U.K. Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Italy Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Russia Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Ireland Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Lung Cancer Screening Software Market Share by Region (2021–2032)

Figure 43. China Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Japan Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. South Korea Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Southeast Asia Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. India Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Australia & New Zealand Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Lung Cancer Screening Software Market Share by Country (2021–2032)

Figure 51. Mexico Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Brazil Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Lung Cancer Screening Software Market Share by Country (2021–2032)

Figure 55. Israel Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Saudi Arabia Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. UAE Lung Cancer Screening Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Siemens Healthineers Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 59. GE HealthCare Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 60. Philips Healthcare Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 61. Canon Medical Systems Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 62. United Imaging Healthcare Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 63. InferVision Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 64. Airdoc Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 65. VUNO Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 66. Lunit Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 67. Qure.ai Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 68. Riverain Technologies Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 69. Zebra Medical Vision Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 70. Arterys Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 71. Deepwise Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 72. EverFortune AI Revenue Growth Rate in Lung Cancer Screening Software Business (2021–2026)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Pulmonology Software Market Research Report 2024

Global Multi Cancer Screening Market Research Report 2024

Global Cervical Cancer Screening Service Market Research Report 2024

Global Lung CT Image assisted Detection Software Market Research Report 2024

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Global Lung AI assisted Diagnosis Software Market Research Report 2024

Global AI Lung Screening System Market Research Report 2024

Lung Cancer Treatment Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Diagnostic And Screening Market Research Report 2024

Global Gynecological Cancer Screening Device Market Research Report 2024

Global Enterprise Information Screening Software Market Research Report 2024

Global Lung Cancer Test Kit Market Research Report 2024

Global Lung Cancer Genomic Testing Market Research Report 2024

Global Cancer Radiation Therapy Software Market Research Report 2024

Global Cancer Patient Registry Software Market Research Report 2025

Global Lung Cancer Diagnostics Kit Market Research Report 2024

Global Portable Cancer Screening Devices Market Research Report 2024

Global Mammography Screening Market Research Report 2024

Global Cervical Screening Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions